Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Sanofi Pasteur signs CRADA with WRAIR on Zika vaccine candidate

July 6, 2016

Pulmocide discloses respiratory syncytial virus fusion inhibitors

July 5, 2016

New aminomethylcycline shows efficacy in pneumonia murine models

July 4, 2016

Arsanis MAbs target the LPS-O antigen of Klebsiella pneumoniae ST258

July 4, 2016

Phase I results for new generation fluoroquinolone lascufloxacin

July 4, 2016

Novel ARF6 inhibitors with robust in vivo efficacy

July 1, 2016

HXP-124 as a novel antifungal agent for the treatment for onychomycosis

July 1, 2016

SER-262 prevents recurrence in patients with primary CDI

June 30, 2016

ACRAF patents DNA gyrase and DNA topoisomerase IV inhibitors

June 30, 2016

Ablynx to license FOX technology for study of inhaled anti-RSV nanobody

June 29, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...